PlainRecalls
FDA Drug Moderate Class II Terminated

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.

Reported: February 13, 2019 Initiated: February 1, 2019 #D-0424-2019

Product Description

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.

Reason for Recall

Defective Container: Potential for broken glass in the neck area of the glass bottles.

Details

Units Affected
10,390 bottles
Distribution
Nationwide in the USA.
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 10,390 bottles.
Why was this product recalled?
Defective Container: Potential for broken glass in the neck area of the glass bottles.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 13, 2019. Severity: Moderate. Recall number: D-0424-2019.